{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T23:06:23Z","timestamp":1792796783412,"version":"4.5.0"},"reference-count":118,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T00:00:00Z","timestamp":1772668800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Aging Neurosci."],"abstract":"<jats:p>\n                    Parkinson\u2019s disease (PD) has long been defined by \u03b1-synuclein aggregation and dopaminergic neurodegeneration, yet growing evidence indicates that non-neuronal contributors, specifically astrocytes and the blood\u2013brain barrier (BBB), may play key roles in disease progression. Human neuropathological studies reveal BBB disruption and astrocytic abnormalities, including plasma protein extravasation, tight junction alterations, and microvascular degeneration in the substantia nigra and striatum, while neuroimaging and fluid biomarkers such as elevated QAlb, plasma GFAP, and CSF S100B further support\n                    <jats:italic>in vivo<\/jats:italic>\n                    vascular compromise and astrocytic reactivity. Complementary postmortem analyses highlight region- and stage-specific changes in both astrocytes and the vasculature. Mechanistic evidence from animal and cell-based models, including \u03b1-synuclein preformed fibrils, transgenic strains, and toxin-induced paradigms, demonstrates that BBB breakdown can precede or parallel dopaminergic loss, accompanied by disrupted astrocyte morphology, impaired end-feet polarization, and altered inflammatory and angiogenic signaling. Experimental manipulation of astrocytic pathways in these systems can either exacerbate or mitigate BBB dysfunction, underscoring a bidirectional astrocyte\u2013vascular axis in PD pathology. Together, these findings position BBB and astrocytic dysfunction as intertwined processes that may amplify neurodegeneration, while underscoring critical gaps, including limited longitudinal human data, uncertain temporal ordering, and the need for integrative multimodal approaches, that must be addressed to determine whether astrocyte, BBB dysfunction drives disease progression or represents a secondary response, and whether it can be targeted for therapeutic intervention.\n                  <\/jats:p>","DOI":"10.3389\/fnagi.2026.1765195","type":"journal-article","created":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T06:55:35Z","timestamp":1772693735000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Interconnected roles of astrocytes and the blood\u2013brain barrier in Parkinson\u2019s disease: pathological evidence, mechanistic insights, and knowledge gaps"],"prefix":"10.3389","volume":"18","author":[{"given":"Anna C.","family":"Stoll","sequence":"first","affiliation":[{"name":"Killion Center for Neurodegeneration and Experimental Therapeutics, University of Alabama at Birmingham","place":["Birmingham, AL, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley S.","family":"Harms","sequence":"additional","affiliation":[{"name":"Killion Center for Neurodegeneration and Experimental Therapeutics, University of Alabama at Birmingham","place":["Birmingham, AL, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,3,5]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"593026","DOI":"10.3389\/fphys.2020.593026","article-title":"Blood\u2013Brain barrier leakage is increased in Parkinson\u2019s disease.","volume":"11","author":"Al-Bachari","year":"2020","journal-title":"Front. Physiol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1939","DOI":"10.1002\/glia.22575","article-title":"Glial influence on the blood brain barrier.","volume":"61","author":"Alvarez","year":"2013","journal-title":"Glia"},{"key":"B3","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.neulet.2013.12.030","article-title":"Heterogeneity of reactive astrocytes.","volume":"565","author":"Anderson","year":"2014","journal-title":"Neurosci. Lett."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1007\/s00018-020-03673-x","article-title":"Emerging role of S100B protein implication in Parkinson\u2019s disease pathogenesis.","volume":"78","author":"Angelopoulou","year":"2021","journal-title":"Cell. Mol. Life Sci. CMLS"},{"key":"B5","doi-asserted-by":"publisher","first-page":"2330","DOI":"10.1002\/glia.24254","article-title":"Extracellular S100B inhibits A-type voltage-gated potassium currents and increases L-type voltage-gated calcium channel activity in dopaminergic neurons.","volume":"70","author":"Bancroft","year":"2022","journal-title":"Glia"},{"key":"B6","doi-asserted-by":"publisher","first-page":"812212","DOI":"10.3389\/fphys.2021.812212","article-title":"Emerging roles for aberrant astrocytic calcium signals in Parkinson\u2019s disease.","volume":"12","author":"Bancroft","year":"2022","journal-title":"Front. Physiol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"608026","DOI":"10.3389\/fcell.2020.608026","article-title":"Mitochondrial dysfunction in astrocytes: A role in Parkinson\u2019s disease?","volume":"8","author":"Bantle","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1007\/s00702-004-0256-2","article-title":"Changes in vascularization in substantia nigra pars compacta of monkeys rendered parkinsonian.","volume":"112","author":"Barcia","year":"2005","journal-title":"J. Neural Trans."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1007\/s00702-008-0030-y","article-title":"Decreased blood\u2013brain barrier P-glycoprotein function in the progression of Parkinson\u2019s disease, PSP and MSA.","volume":"115","author":"Bartels","year":"2008","journal-title":"J. Neural Trans."},{"key":"B10","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1007\/s00401-017-1755-1","article-title":"Alpha-synuclein oligomers: A new hope.","volume":"134","author":"Bengoa-Vergniory","year":"2017","journal-title":"Acta Neuropathol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"2337","DOI":"10.1096\/fj.03-0291fje","article-title":"Sonic hedgehog is a neuromodulator in the adult subthalamic nucleus.","volume":"17","author":"Bezard","year":"2003","journal-title":"FASEB J."},{"key":"B12","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.tins.2017.04.001","article-title":"The role of astrocyte dysfunction in Parkinson\u2019s disease pathogenesis.","volume":"40","author":"Booth","year":"2017","journal-title":"Trends Neurosci."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1610","DOI":"10.1212\/01.WNL.0000068008.78394.2C","article-title":"Head trauma preceding PD.","volume":"60","author":"Bower","year":"2003","journal-title":"Neurology"},{"key":"B14","doi-asserted-by":"publisher","first-page":"71","DOI":"10.3390\/neurosci5010005","article-title":"The role of astrocytes and alpha-synuclein in Parkinson\u2019s disease: A review.","volume":"5","author":"Brash-Arias","year":"2024","journal-title":"NeuroScience"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1101\/2024.08.14.607971","article-title":"Aquaporin-4 mis-localization slows glymphatic clearance of \u03b1-synuclein and promotes \u03b1-synuclein pathology and aggregate propagation.","author":"Braun","year":"2024","journal-title":"bioRxiv [Preprint]"},{"key":"B16","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1172\/JCI36470","article-title":"Infiltration of CD4 + lymphocytes into the brain contributes to neurodegeneration in a mouse model of Parkinson disease.","volume":"119","author":"Brochard","year":"2009","journal-title":"J. Clin. Invest."},{"key":"B17","doi-asserted-by":"publisher","first-page":"211","DOI":"10.3389\/fncel.2014.00211","article-title":"Astrocytic modulation of blood brain barrier: Perspectives on Parkinson\u2019s disease.","volume":"8","author":"Cabezas","year":"2014","journal-title":"Front. Cell. Neurosci."},{"key":"B18","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.neulet.2015.10.010","article-title":"Overnight S100B in Parkinson\u2019s disease: A glimpse into sleep-related neuroinflammation.","volume":"608","author":"Carvalho","year":"2015","journal-title":"Neurosci. Lett."},{"key":"B19","doi-asserted-by":"publisher","first-page":"e177002","DOI":"10.1172\/jci.insight.177002","article-title":"Neuronal DAMPs exacerbate neurodegeneration via astrocytic RIPK3 signaling.","volume":"9","author":"Chang","year":"2024","journal-title":"JCI Insight"},{"key":"B20","doi-asserted-by":"publisher","first-page":"308654","DOI":"10.1155\/2014\/308654","article-title":"Evidence of inflammatory system involvement in Parkinson\u2019s disease.","volume":"2014","author":"Chao","year":"2014","journal-title":"BioMed. Res. Intern."},{"key":"B21","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s12987-024-00557-1","article-title":"Cellular and molecular mechanisms of the blood\u2013brain barrier dysfunction in neurodegenerative diseases.","volume":"21","author":"Chen","year":"2024","journal-title":"Fluids Barriers CNS"},{"key":"B22","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1038\/s41419-021-04049-0","article-title":"Fibrillar \u03b1-synuclein induces neurotoxic astrocyte activation via RIP kinase signaling and NF-\u03baB.","volume":"12","author":"Chou","year":"2021","journal-title":"Cell Death Dis."},{"key":"B23","doi-asserted-by":"publisher","first-page":"a020370","DOI":"10.1101\/cshperspect.a020370","article-title":"Astrocytes control synapse formation, function, and elimination","volume":"7","author":"Chung","year":"2015","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"2500","DOI":"10.1007\/s12031-021-01836-4","article-title":"Decreased AQP4 expression aggravates \u0251-Synuclein pathology in Parkinson\u2019s disease mice, possibly via impaired glymphatic clearance.","volume":"71","author":"Cui","year":"2021","journal-title":"J. Mol. Neurosci."},{"key":"B25","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1186\/s40478-023-01624-8","article-title":"Human Alzheimer\u2019s disease reactive astrocytes exhibit a loss of homeostastic gene expression.","volume":"11","author":"Dai","year":"2023","journal-title":"Acta Neuropathol. Commun."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0306-4522(93)90175-F","article-title":"Glutathione peroxidase, glial cells and Parkinson\u2019s disease.","volume":"52","author":"Damier","year":"1993","journal-title":"Neuroscience"},{"key":"B27","doi-asserted-by":"publisher","first-page":"3651","DOI":"10.1038\/s41467-023-39038-8","article-title":"The contribution of inflammatory astrocytes to BBB impairments in a brain-chip model of Parkinson\u2019s disease.","volume":"14","author":"de Rus Jacquet","year":"2023","journal-title":"Nat. Commun."},{"key":"B28","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s00702-011-0684-8","article-title":"Evidence for angiogenesis in Parkinson\u2019s disease, incidental Lewy body disease, and progressive supranuclear palsy.","volume":"119","author":"Desai Bradaric","year":"2012","journal-title":"J. Neural Trans."},{"key":"B29","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1146\/annurev-neuro-091922-031205","article-title":"Astrocyte endfeet in brain function and pathology: Open questions.","volume":"46","author":"D\u00edaz-Castro","year":"2023","journal-title":"Ann. Rev. Neurosci."},{"key":"B30","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1093\/brain\/awaf305","article-title":"Region-specific variations in the cerebrovasculature underlie disease progression in Parkinson\u2019s disease.","volume":"149","author":"Dik","year":"2025","journal-title":"Brain"},{"key":"B31","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.mvr.2019.03.005","article-title":"Monomeric \u03b1-synuclein induces blood\u2013brain barrier dysfunction through activated brain pericytes releasing inflammatory mediators in vitro.","volume":"124","author":"Dohgu","year":"2019","journal-title":"Microvas. Res."},{"key":"B32","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1186\/s12974-018-1371-6","article-title":"Profiling the proteomic inflammatory state of human astrocytes using DIA mass spectrometry.","volume":"15","author":"Dozio","year":"2018","journal-title":"J. Neuroinflamm."},{"key":"B33","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1186\/s13287-025-04660-4","article-title":"Three-dimensional midbrain organoids: A next-generation tool for Parkinson\u2019s disease modelling and drug discovery.","volume":"16","author":"Elvira","year":"2025","journal-title":"Stem Cell Res. Therapy"},{"key":"B34","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1016\/j.neurobiolaging.2007.02.015","article-title":"Hypersensitivity of aquaporin 4-deficient mice to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyrindine and astrocytic modulation.","volume":"29","author":"Fan","year":"2008","journal-title":"Neurobiol. Aging"},{"key":"B35","doi-asserted-by":"publisher","first-page":"740491","DOI":"10.3389\/fnagi.2021.740491","article-title":"Aquaporin-4 polymorphisms are associated with cognitive performance in Parkinson\u2019s disease.","volume":"13","author":"Fang","year":"2022","journal-title":"Front. Aging Neurosci."},{"key":"B36","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s12881-018-0547-3","article-title":"S100B polymorphisms are associated with age of onset of Parkinson\u2019s disease.","volume":"19","author":"Fardell","year":"2018","journal-title":"BMC Med. Genet."},{"key":"B37","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1007\/s004010000195","article-title":"Pathological features of cerebral cortical capillaries are doubled in Alzheimer\u2019s disease and Parkinson\u2019s disease.","volume":"100","author":"Farkas","year":"2000","journal-title":"Acta Neuropathol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1016\/S0140-6736(99)00641-8","article-title":"Blood vessels change in the mesencephalon of patients with Parkinson\u2019s disease.","volume":"353","author":"Faucheux","year":"1999","journal-title":"Lancet"},{"key":"B39","doi-asserted-by":"publisher","first-page":"2246","DOI":"10.1007\/s00415-021-10411-1","article-title":"Blood-brain barrier permeability in Parkinson\u2019s disease patients with and without dyskinesia","volume":"268","author":"Fujita","year":"2021","journal-title":"J. Neurol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1038\/jcbfm.2015.32","article-title":"Striatal blood\u2013brain barrier permeability in Parkinson\u2019s disease.","volume":"35","author":"Gray","year":"2015","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"B41","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1111\/j.1750-3639.2012.00628.x","article-title":"Vascular degeneration in Parkinson\u2019s disease.","volume":"23","author":"Guan","year":"2013","journal-title":"Brain Pathol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1007\/s00401-021-02268-5","article-title":"Periphery and brain, innate and adaptive immunity in Parkinson\u2019s disease.","volume":"141","author":"Harms","year":"2021","journal-title":"Acta Neuropathol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/S0304-3940(01)01574-9","article-title":"Integrity of the blood-cerebrospinal fluid barrier in early Parkinson\u2019s disease","volume":"300","author":"Haussermann","year":"2001","journal-title":"Neurosci. Lett."},{"key":"B44","doi-asserted-by":"publisher","first-page":"8895","DOI":"10.1038\/s41467-025-63945-7","article-title":"In vivo imaging of the barrier properties of the glia limitans during health and neuroinflammation.","volume":"16","author":"H\u00e9lie-Legoupil","year":"2025","journal-title":"Nat. Commun."},{"key":"B45","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1002\/ajmg.b.30950","article-title":"Risk variants in the S100B gene predict elevated S100B serum concentrations in healthy individuals.","author":"Hohoff","year":"2010","journal-title":"Am. J. Med. Genet. Part B: Neuropsychiatric Genet."},{"key":"B46","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.ijbiomac.2022.12.134","article-title":"The impact of \u03b1-synuclein aggregates on blood-brain barrier integrity in the presence of neurovascular unit cells.","volume":"229","author":"Hourfar","year":"2023","journal-title":"Intern. J. Biol. Macromol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.bbi.2022.09.002","article-title":"Transfer of neuron-derived \u03b1-synuclein to astrocytes induces neuroinflammation and blood\u2013brain barrier damage after methamphetamine exposure: Involving the regulation of nuclear receptor-associated protein 1.","volume":"106","author":"Huang","year":"2022","journal-title":"Brain Behav. Immun."},{"key":"B48","doi-asserted-by":"publisher","first-page":"2077","DOI":"10.1093\/brain\/awt134","article-title":"Parkinson\u2019s disease is associated with altered expression of CaV1 channels and calcium-binding proteins.","volume":"136","author":"Hurley","year":"2013","journal-title":"Brain"},{"key":"B49","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/0006-8993(71)90439-2","article-title":"Neuronal vascular relationships in the zona compacta of normal and parkinsonian substantia nigra.","volume":"25","author":"Issidorides","year":"1971","journal-title":"Brain Res."},{"key":"B50","doi-asserted-by":"publisher","first-page":"e60925","DOI":"10.3791\/60925","article-title":"Generation of a human iPSC-Based blood-brain barrier chip.","author":"Jagadeesan","year":"2020","journal-title":"J. Visual. Exp."},{"key":"B51","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.1212\/WNL.0000000000002151","article-title":"Increased CSF biomarkers of angiogenesis in Parkinson disease.","volume":"85","author":"Janelidze","year":"2015","journal-title":"Neurology"},{"key":"B52","doi-asserted-by":"publisher","first-page":"116001","DOI":"10.1016\/j.celrep.2025.116001","article-title":"TNF-\u03b1-NF-\u03baB activation through pathological \u03b1-Synuclein disrupts the BBB and exacerbates axonopathy.","volume":"44","author":"Jeon","year":"2025","journal-title":"Cell Rep."},{"key":"B53","doi-asserted-by":"publisher","first-page":"622","DOI":"10.3390\/cells12040622","article-title":"Role of astrocytes in Parkinson\u2019s disease associated with genetic mutations and neurotoxicants.","volume":"12","author":"Kim","year":"2023","journal-title":"Cells"},{"key":"B54","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/S1353-8020(99)00022-X","article-title":"Astrocytes and microglia in the substantia nigra and caudate-putamen in Parkinson\u2019s disease.","volume":"5","author":"Knott","year":"1999","journal-title":"Parkinson. Related Disord."},{"key":"B55","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1002\/ana.20369","article-title":"Blood\u2013brain barrier dysfunction in parkinsonian midbrain in vivo.","volume":"57","author":"Kortekaas","year":"2005","journal-title":"Ann. Neurol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.expneurol.2016.09.003","article-title":"\u03b1-Synuclein pre-formed fibrils impair tight junction protein expression without affecting cerebral endothelial cell function.","volume":"285","author":"Kuan","year":"2016","journal-title":"Exp. Neurol."},{"key":"B57","doi-asserted-by":"publisher","first-page":"32","DOI":"10.3389\/fneur.2013.00032","article-title":"Matrix metalloproteinases and blood-brain barrier disruption in acute ischemic stroke.","volume":"4","author":"Lakhan","year":"2013","journal-title":"Front. Neurol."},{"key":"B58","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1002\/glia.24109","article-title":"Astrocytic VEGFA: An essential mediator in blood\u2013brain-barrier disruption in Parkinson\u2019s disease.","volume":"70","author":"Lan","year":"2021","journal-title":"Glia"},{"key":"B59","doi-asserted-by":"publisher","first-page":"1672","DOI":"10.3390\/ijms25031672","article-title":"Aquaporin-4 and Parkinson\u2019s disease.","volume":"25","author":"Lapshina","year":"2024","journal-title":"Intern. J. Mol. Sci."},{"key":"B60","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/s41593-019-0541-x","article-title":"\u03b1-Synuclein strains target distinct brain regions and cell types.","volume":"23","author":"Lau","year":"2020","journal-title":"Nat. Neurosci."},{"key":"B61","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s40035-024-00430-z","article-title":"Blood\u2013brain barrier alterations and their impact on Parkinson\u2019s disease pathogenesis and therapy.","volume":"13","author":"Lau","year":"2024","journal-title":"Trans. Neurodegenerat."},{"key":"B62","doi-asserted-by":"publisher","first-page":"106298","DOI":"10.1016\/j.nbd.2023.106298","article-title":"Microvascular blood-brain barrier alterations in isolated brain capillaries of mice over-expressing alpha-synuclein (Thy1-aSyn line 61).","volume":"187","author":"Lau","year":"2023","journal-title":"Neurobiol. Dis."},{"key":"B63","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s40478-019-0716-4","article-title":"Parkinson\u2019s disease-associated LRRK2-G2019S mutant acts through regulation of SERCA activity to control ER stress in astrocytes.","volume":"7","author":"Lee","year":"2019","journal-title":"Acta Neuropathol. Commun."},{"key":"B64","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1186\/s12916-023-03120-1","article-title":"Plasma glial fibrillary acidic protein as a biomarker of disease progression in Parkinson\u2019s disease: A prospective cohort study.","volume":"21","author":"Lin","year":"2023","journal-title":"BMC Med."},{"key":"B65","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.mcn.2017.04.009","article-title":"Extensive uptake of \u03b1-synuclein oligomers in astrocytes results in sustained intracellular deposits and mitochondrial damage.","volume":"82","author":"Lindstr\u00f6m","year":"2017","journal-title":"Mol. Cell. Neurosci."},{"key":"B66","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1007\/s00259-021-05640-5","article-title":"PET imaging of reactive astrocytes in neurological disorders.","volume":"49","author":"Liu","year":"2022","journal-title":"Eur. J. Nuclear Med. Mol. Imag."},{"key":"B67","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/j.jns.2015.10.011","article-title":"Increased albumin CSF\/serum ratio in dementia with Lewy bodies.","volume":"358","author":"Llorens","year":"2015","journal-title":"J. Neurol. Sci."},{"key":"B68","doi-asserted-by":"publisher","first-page":"17146","DOI":"10.3390\/ijms242417146","article-title":"Astrocyte involvement in blood-brain barrier function: a critical update highlighting novel, complex, neurovascular interactions","volume":"24","author":"Manu","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"B69","doi-asserted-by":"publisher","first-page":"571","DOI":"10.3390\/ijms20030571","article-title":"Dual roles of astrocyte-derived factors in regulation of blood-brain barrier function after brain damage.","volume":"20","author":"Michinaga","year":"2019","journal-title":"Intern. J. Mol. Sci."},{"key":"B70","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/164_2017_1","article-title":"The mitochondrial Ca2 + uniporter: structure, function, and pharmacology.","volume":"240","author":"Mishra","year":"2017","journal-title":"Handb. Exp. Pharmacol."},{"key":"B71","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1007\/s00401-023-02547-3","article-title":"Dysregulation of astrocytic Ca2+ signaling and gliotransmitter release in mouse models of \u03b1-synucleinopathies.","volume":"145","author":"Nanclares","year":"2023","journal-title":"Acta Neuropathol."},{"key":"B72","doi-asserted-by":"publisher","first-page":"2665","DOI":"10.1093\/brain\/awh625","article-title":"A possible role for humoral immunity in the pathogenesis of Parkinson\u2019s disease.","volume":"128","author":"Orr","year":"2005","journal-title":"Brain"},{"key":"B73","doi-asserted-by":"publisher","first-page":"20160154","DOI":"10.1098\/rstb.2016.0154","article-title":"Astrocytic control of synaptic function","volume":"372","author":"Papouin","year":"2017","journal-title":"Philos. Trans. R. Soc. Lond. B. Biol. Sci."},{"key":"B74","doi-asserted-by":"publisher","first-page":"156","DOI":"10.3389\/fnagi.2020.00156","article-title":"Increased cerebrospinal fluid s100b and nse reflect neuronal and glial damage in Parkinson\u2019s disease.","volume":"12","author":"Papu\u0107","year":"2020","journal-title":"Front. Aging Neurosci."},{"key":"B75","doi-asserted-by":"publisher","first-page":"838","DOI":"10.2967\/jnumed.113.131854","article-title":"Evaluation of 11 C-BU99008, a PET ligand for the imidazoline2 binding sites in rhesus brain.","volume":"55","author":"Parker","year":"2014","journal-title":"J. Nuclear Med."},{"key":"B76","doi-asserted-by":"publisher","first-page":"853372","DOI":"10.3389\/fnagi.2022.853372","article-title":"Microvascular changes in Parkinson\u2019s disease- focus on the neurovascular unit.","volume":"14","author":"Paul","year":"2022","journal-title":"Front. Aging Neurosci."},{"key":"B77","doi-asserted-by":"publisher","first-page":"5907","DOI":"10.1038\/s41467-021-26066-5","article-title":"Modeling alpha-synuclein pathology in a human brain-chip to assess blood-brain barrier disruption.","volume":"12","author":"Pediaditakis","year":"2021","journal-title":"Nat. Commun."},{"key":"B78","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/j.nbd.2014.12.006","article-title":"Deep-brain stimulation associates with improved microvascular integrity in the subthalamic nucleus in Parkinson\u2019s disease.","volume":"74","author":"Pienaar","year":"2015","journal-title":"Neurobiol. Dis."},{"key":"B79","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1186\/1742-2094-9-188","article-title":"Increased blood-cerebrospinal fluid transfer of albumin in advanced Parkinson\u2019s disease.","volume":"9","author":"Pisani","year":"2012","journal-title":"J. Neuroinflamm."},{"key":"B80","doi-asserted-by":"publisher","first-page":"2538","DOI":"10.1007\/s11064-021-03338-6","article-title":"Astrocyte\u2013Endotheliocyte axis in the regulation of the blood\u2013brain barrier.","volume":"46","author":"Pivori\u00fbnas","year":"2021","journal-title":"Neurochem. Res."},{"key":"B81","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1111\/j.1471-4159.2007.04567.x","article-title":"Blood\u2013brain barrier disruption induces in vivo degeneration of nigral dopaminergic neurons.","volume":"101","author":"Rite","year":"2007","journal-title":"J. Neurochem."},{"key":"B82","doi-asserted-by":"publisher","first-page":"3336","DOI":"10.1093\/brain\/aws250","article-title":"S100B is increased in Parkinson\u2019s disease and ablation protects against MPTP-induced toxicity through the RAGE and TNF-\u03b1 pathway.","volume":"135","author":"Sathe","year":"2012","journal-title":"Brain: A J. Neurol."},{"key":"B83","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1186\/s12967-024-05441-y","article-title":"Insights to Ang\/Tie signaling pathway: Another rosy dawn for treating retinal and choroidal vascular diseases.","volume":"22","author":"Sha","year":"2024","journal-title":"J. Trans. Med."},{"key":"B84","doi-asserted-by":"publisher","first-page":"101044","DOI":"10.1016\/j.bbih.2025.101044","article-title":"Proinflammatory transcriptomic and kinomic alterations in astrocytes derived from patients with familial Alzheimer\u2019s disease.","volume":"47","author":"Siciliano","year":"2025","journal-title":"Brain Behav. Immun. Health"},{"key":"B85","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s00401-009-0619-8","article-title":"Astrocytes: Biology and pathology.","volume":"119","author":"Sofroniew","year":"2010","journal-title":"Acta Neuropathol."},{"key":"B86","doi-asserted-by":"publisher","first-page":"14474","DOI":"10.1038\/s41598-020-71329-8","article-title":"Metabolic alterations in Parkinson\u2019s disease astrocytes.","volume":"10","author":"Sonninen","year":"2020","journal-title":"Sci. Rep."},{"key":"B87","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s13024-017-0182-z","article-title":"Intrastriatal injection of \u03b1-synuclein can lead to widespread synucleinopathy independent of neuroanatomic connectivity.","volume":"12","author":"Sorrentino","year":"2017","journal-title":"Mol. Neurodegenerat."},{"key":"B88","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00401-019-01977-2","article-title":"\u03b1-Synuclein and astrocytes: Tracing the pathways from homeostasis to neurodegeneration in Lewy body disease.","volume":"138","author":"Sorrentino","year":"2020","journal-title":"Acta Neuropathol."},{"key":"B89","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.3389\/fphar.2019.01346","article-title":"Astrocyte-Derived paracrine signals: Relevance for neurogenic niche regulation and blood\u2013brain barrier integrity.","volume":"10","author":"Spampinato","year":"2019","journal-title":"Front. Pharmacol."},{"key":"B90","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1001\/archneur.1991.00530210029018","article-title":"The epidemiology of Parkinson\u2019s disease.","volume":"48","author":"Stern","year":"1991","journal-title":"Arch. Neurol."},{"key":"B91","doi-asserted-by":"publisher","first-page":"17314","DOI":"10.1038\/s41598-022-20261-0","article-title":"Pericytes take up and degrade \u03b1-synuclein but succumb to apoptosis under cellular stress.","volume":"12","author":"Stevenson","year":"2022","journal-title":"Sci. Rep."},{"key":"B92","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.clineuro.2011.11.002","article-title":"Correlational study of the serum levels of the glial fibrillary acidic protein and neurofilament proteins in Parkinson\u2019s disease patients.","volume":"114","author":"Su","year":"2012","journal-title":"Clin. Neurol. Neurosurg."},{"key":"B93","doi-asserted-by":"publisher","first-page":"18","DOI":"10.5214\/ans.0972-7531.2010.170102","article-title":"Neuroprotective action of piper longum against MPTP-induced changes in mouse brain.","volume":"17","author":"Subburaman","year":"2010","journal-title":"Ann. Neurosci."},{"key":"B94","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.peptides.2014.09.018","article-title":"Alpha synuclein is transported into and out of the brain by the blood\u2013brain barrier.","volume":"62","author":"Sui","year":"2014","journal-title":"Peptides"},{"key":"B95","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.neuroscience.2016.01.003","article-title":"Aquaporin-4 mediates communication between astrocyte and microglia: Implications of neuroinflammation in experimental Parkinson\u2019s disease.","volume":"317","author":"Sun","year":"2016","journal-title":"Neuroscience"},{"key":"B96","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/s41531-023-00447-7","article-title":"Plasma GFAP in Parkinson\u2019s disease with cognitive impairment and its potential to predict conversion to dementia.","volume":"9","author":"Tang","year":"2023","journal-title":"NPJ Parkinson\u2019s Dis."},{"key":"B97","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1007\/s11064-011-0637-5","article-title":"Peripheral assessment of the genes AQP4, PBP and TH in patients with Parkinson\u2019s disease.","volume":"37","author":"Thamizh Thenral","year":"2012","journal-title":"Neurochem. Res."},{"key":"B98","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.nbd.2004.01.010","article-title":"Minocycline reduces the lipopolysaccharide-induced inflammatory reaction, peroxynitrite-mediated nitration of proteins, disruption of the blood\u2013brain barrier, and damage in the nigral dopaminergic system.","volume":"16","author":"Tom\u00e1s-Camardiel","year":"2004","journal-title":"Neurobiol. Dis."},{"key":"B99","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.nbd.2015.06.010","article-title":"Low levels of astroglial markers in Parkinson\u2019s disease: Relationship to \u03b1-synuclein accumulation.","volume":"82","author":"Tong","year":"2015","journal-title":"Neurobiol. Dis."},{"key":"B100","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/S0303-8467(02)00027-6","article-title":"Environmental risk factors of young onset Parkinson\u2019s disease: A case-control study.","volume":"104","author":"Tsai","year":"2002","journal-title":"Clin. Neurol. Neurosurg."},{"key":"B101","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.2967\/jnumed.118.208009","article-title":"Evaluation of 11 C-BU99008, a PET Ligand for the Imidazoline 2 Binding Site in Human Brain.","volume":"59","author":"Tyacke","year":"2018","journal-title":"J. Nuclear Med."},{"key":"B102","doi-asserted-by":"publisher","first-page":"8434","DOI":"10.3390\/ijms24098434","article-title":"Functions of astrocytes under normal conditions and after a brain disease","volume":"24","author":"Valles","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"B103","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1007\/s00401-020-02157-3","article-title":"The structural differences between patient-derived \u03b1-synuclein strains dictate characteristics of Parkinson\u2019s disease, multiple system atrophy and dementia with Lewy bodies.","volume":"139","author":"Van der Perren","year":"2020","journal-title":"Acta Neuropathol."},{"key":"B104","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1006\/nbdi.1999.0246","article-title":"Differential upregulation of Aquaporin-4 mRNA expression in reactive astrocytes after brain injury: Potential role in brain edema.","volume":"6","author":"Vizuete","year":"1999","journal-title":"Neurobiol. Dis."},{"key":"B105","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.bbr.2012.04.005","article-title":"6-Hydroxydopamine leads to T2 hyperintensity, decreased claudin-3 immunoreactivity and altered aquaporin 4 expression in the striatum.","volume":"232","author":"Wachter","year":"2012","journal-title":"Behav. Brain Res."},{"key":"B106","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1097\/01.wnr.0000215769.71657.65","article-title":"Expression levels of vascular endothelial growth factor and its receptors in Parkinson\u2019s disease.","volume":"17","author":"Wada","year":"2006","journal-title":"NeuroReport"},{"key":"B107","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s40035-021-00265-y","article-title":"Astrocyte dysfunction in Parkinson\u2019s disease: From the perspectives of transmitted \u03b1-synuclein and genetic modulation.","volume":"10","author":"Wang","year":"2021","journal-title":"Trans. Neurodegenerat."},{"key":"B108","doi-asserted-by":"publisher","first-page":"938","DOI":"10.3390\/life11090938","article-title":"Astrocytes in neurodegenerative diseases: A perspective from tauopathy and \u03b1-Synucleinopathy.","volume":"11","author":"Wang","year":"2021","journal-title":"Life"},{"key":"B109","doi-asserted-by":"publisher","first-page":"2336","DOI":"10.3390\/cells12192336","article-title":"Astrocytes in Parkinson\u2019s disease: From role to possible intervention.","volume":"12","author":"Wang","year":"2023","journal-title":"Cells"},{"key":"B110","doi-asserted-by":"publisher","first-page":"1874","DOI":"10.3390\/cells13221874","article-title":"Dysregulated coagulation in Parkinson\u2019s disease.","volume":"13","author":"Wang","year":"2024","journal-title":"Cells"},{"key":"B111","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.1093\/brain\/awab103","article-title":"CD4 T cells mediate brain inflammation and neurodegeneration in a mouse model of Parkinson\u2019s disease.","volume":"144","author":"Williams","year":"2021","journal-title":"Brain"},{"key":"B112","doi-asserted-by":"publisher","first-page":"3116","DOI":"10.1093\/brain\/awz260","article-title":"Imidazoline 2 binding sites reflecting astroglia pathology in Parkinson\u2019s disease: An in vivo11C-BU99008 PET study.","volume":"142","author":"Wilson","year":"2019","journal-title":"Brain"},{"key":"B113","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1016\/j.celrep.2014.10.023","article-title":"iPSC-Derived dopamine neurons reveal differences between monozygotic twins discordant for Parkinson\u2019s disease.","volume":"9","author":"Woodard","year":"2014","journal-title":"Cell Rep."},{"key":"B114","doi-asserted-by":"publisher","first-page":"2568","DOI":"10.1111\/jcmm.14147","article-title":"Aquaporin-4 deficiency reduces TGF\u2212\u03b21 in mouse midbrains and exacerbates pathology in experimental Parkinson\u2019s disease.","volume":"23","author":"Xue","year":"2019","journal-title":"J. Cell. Mol. Med."},{"key":"B115","doi-asserted-by":"publisher","first-page":"100074","DOI":"10.1016\/j.bionps.2023.100074","article-title":"Biomarkers in Parkinson\u2019s disease: A state of the art review.","volume":"9","author":"Yamashita","year":"2023","journal-title":"Biomarkers Neuropsychiatry"},{"key":"B116","doi-asserted-by":"publisher","first-page":"821","DOI":"10.3233\/JPD-140454","article-title":"String vessel formation is increased in the brain of Parkinson disease.","volume":"5","author":"Yang","year":"2015","journal-title":"J. Parkinson\u2019s Dis."},{"key":"B117","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1038\/s41514-023-00102-8","article-title":"Aging reduces calreticulin expression and alters spontaneous calcium signals in astrocytic endfeet of the mouse dorsolateral striatum.","volume":"9","author":"Zarate","year":"2023","journal-title":"NPJ Aging"},{"key":"B118","doi-asserted-by":"publisher","first-page":"2209","DOI":"10.1007\/s12035-023-03212-2","article-title":"Interaction between the glymphatic system and \u03b1-Synuclein in Parkinson\u2019s disease.","volume":"60","author":"Zhang","year":"2023","journal-title":"Mol. Neurobiol."}],"container-title":["Frontiers in Aging Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnagi.2026.1765195\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T06:55:37Z","timestamp":1772693737000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnagi.2026.1765195\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,5]]},"references-count":118,"alternative-id":["10.3389\/fnagi.2026.1765195"],"URL":"https:\/\/doi.org\/10.3389\/fnagi.2026.1765195","relation":{},"ISSN":["1663-4365"],"issn-type":[{"value":"1663-4365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,5]]},"article-number":"1765195"}}